Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by newcoinon Aug 20, 2023 9:56am
189 Views
Post# 35596864

RE:RE:RE:RE:RE:RE:RE:Thoughts on pan can deal

RE:RE:RE:RE:RE:RE:RE:Thoughts on pan can deal

inthno, are you still thinking the same way as in this June post? Things change quickly and the summer is slow. Nobody knows. I just want to know if you're as positive as you were a few months ago. I really value your opinion.

inthno wrote: A lot of good comments and thoughts for sure and most likely the best PR we have had overall in years as this sets the stage for everything that onc has worked for.
Now the big question and really should be no question at all in regards to the ci that should be included in the precision trial....There would be no way that onc would or should take a chance with a different ci knowing that it was Pela in combination with gem and Roche that brought us to that point. Why the specific ci was not mentioned is indeed most interesting and maybe a strong point if it is a part of the bargaining but I think that they really have no choice so am going to go with Roche and either a partnership or BO before year end. UGH I ususally do not like predictions but the stage is set and no one in their right mind would take a chance of onc going it alone and taking it all for themselves especially with everythng else that onc brings to the table and so close to it all coming down quickly.
It is finally our time so just gotta let it happen.


 

<< Previous
Bullboard Posts
Next >>